Prospective superficial EPR in-vivo dosimetry study during hypofractionated radiotherapy of breast cancer patients treated with helical tomotherapy

In-vivo dosimetry (IVD) is a patient specific measure of quality control and safety during radiotherapy. With regard to current reporting thresholds for significant occurrences in radiotherapy defined by German regulatory authorities, the present study examines the clinical feasibility of superficia...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Höfel, Sebastian (VerfasserIn) , Gandalini, Matteo (VerfasserIn) , Fix, Michael K. (VerfasserIn) , Drescher, Malte (VerfasserIn) , Zwicker, Felix (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 30 October 2021
In: Radiation oncology
Year: 2021, Jahrgang: 16, Pages: 1-13
ISSN:1748-717X
DOI:10.1186/s13014-021-01938-8
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/s13014-021-01938-8
Volltext
Verfasserangaben:Sebastian Höfel, Matteo Gandalini, Michael K. Fix, Malte Drescher and Felix Zwicker
Beschreibung
Zusammenfassung:In-vivo dosimetry (IVD) is a patient specific measure of quality control and safety during radiotherapy. With regard to current reporting thresholds for significant occurrences in radiotherapy defined by German regulatory authorities, the present study examines the clinical feasibility of superficial electron paramagnetic resonance (EPR) IVD of cumulative total doses applied to breast cancer patients treated with helical intensity-modulated radiotherapy (tomotherapy).
Beschreibung:Gesehen am 04.02.2022
Beschreibung:Online Resource
ISSN:1748-717X
DOI:10.1186/s13014-021-01938-8